EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro

Anqi Li, Siyuan He, Jingren Li, Zhemin Zhang, Bing Li, Haiqing Chu iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.00718-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Anqi Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Mycobacterium abscessus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China, Natural Science Foundation of Shanghai, Science and Technology Innovation Plan Of Shanghai Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antimicrobial activities of four third-generation tetracycline-class drugs, omadacycline (OMC), eravacycline (ERC), tigecycline (TGC), and sarecycline (SAC), were determined for 193 M. abscessus isolates. The activities of the four drugs at two different temperatures (30°C and 37°C) were also tested.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusTigecyclineTetracyclinesAnti-Bacterial Agents

Stichwörter der Autor:innen

Mycobacterium abscessuseravacyclinein vitroomadacyclinesarecyclinetetracyclinetigecycline

Substanzen

sarecyclineTigecyclineomadacyclineeravacyclineTetracyclinesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • School of Medicine, Tongji University, Shanghai, China.
  • Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Haiqing Chu

Förderung

  • MOST | National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai
  • Science and Technology Innovation Plan Of Shanghai Science and Technology Commission
  • Zhongnanshan Medical Foundation of Guangdong Province
  • Clinical Research Foundation of Shanghai Pulmonary Hospital

Zitieren

APA

Li, A., He, S., Li, J., Zhang, Z., Li, B., & Chu, H. (2023). Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00718-23

Vancouver

Li A, He S, Li J, Zhang Z, Li B, Chu H. Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro. Microbiology Spectrum. 2023. doi:10.1128/spectrum.00718-23

BibTeX
@article{Li2023,
  author = {Li, Anqi and He, Siyuan and Li, Jingren and Zhang, Zhemin and Li, Bing and Chu, Haiqing},
  title = {Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.00718-23}
}
Kostenlos starten →